Hemolytic anemia physical examination: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:


Exam findings in hemolytic anemia include:
Exam findings in hemolytic anemia include:
*'''[[Jaundice]]'''The symptoms of hemolysis mostly relate to (1) red blood cell loss and (2) release of hemoglobin and its breakdown products into the circulation. The breakdown products of [[hemoglobin]] will accumulate in the blood causing [[jaundice]] and be excreted in the urine causing the urine to become dark brown in color. <ref name="pmid21814401">{{cite journal| author=Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK| title=Clinical patterns and hematological spectrum in autoimmune hemolytic anemia. | journal=J Lab Physicians | year= 2010 | volume= 2 | issue= 1 | pages= 17-20 | pmid=21814401 | doi=10.4103/0974-2727.66703 | pmc=3147080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21814401  }} </ref>: This is due to Increased serum [[bilirubin]] levels in [[blood]]. Bilirubin is a breakdown product of hemoglobin. In one population, 43% of patients with hemolytic anemia presented with jaundice. Hemoglobin is first convereted to biliverdin then bilirubin. Jaundice can present as yellow discoloration of the skin or mucus membranes. It is a reflect of indirect (unconjugated) hyperbilirubinemia.
*'''[[Jaundice]]''': The symptoms of hemolysis mostly relate to (1) red blood cell loss and (2) release of hemoglobin and its breakdown products into the circulation. The breakdown products of [[hemoglobin]] will accumulate in the blood causing [[jaundice]] and be excreted in the urine causing the urine to become dark brown in color. <ref name="pmid21814401">{{cite journal| author=Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK| title=Clinical patterns and hematological spectrum in autoimmune hemolytic anemia. | journal=J Lab Physicians | year= 2010 | volume= 2 | issue= 1 | pages= 17-20 | pmid=21814401 | doi=10.4103/0974-2727.66703 | pmc=3147080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21814401  }} </ref>: This is due to Increased serum [[bilirubin]] levels in [[blood]]. Bilirubin is a breakdown product of hemoglobin. In one population, 43% of patients with hemolytic anemia presented with jaundice. Hemoglobin is first convereted to biliverdin then bilirubin. Jaundice can present as yellow discoloration of the skin or mucus membranes. It is a reflect of indirect (unconjugated) hyperbilirubinemia.
*'''[[Pallor]]'''<ref name="pmid21814401">{{cite journal| author=Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK| title=Clinical patterns and hematological spectrum in autoimmune hemolytic anemia. | journal=J Lab Physicians | year= 2010 | volume= 2 | issue= 1 | pages= 17-20 | pmid=21814401 | doi=10.4103/0974-2727.66703 | pmc=3147080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21814401  }} </ref>: This occurs due to anemia and loss of oxygen-carrying ability of blood. Pallor can occur in the [[skin]] or [[mucous membrane]] . In one population, 89% of patients with hemolytic anemia presented with pallor, and this is the most common physical exam finding in hemolytic anemia.
*'''[[Pallor]]'''<ref name="pmid21814401">{{cite journal| author=Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK| title=Clinical patterns and hematological spectrum in autoimmune hemolytic anemia. | journal=J Lab Physicians | year= 2010 | volume= 2 | issue= 1 | pages= 17-20 | pmid=21814401 | doi=10.4103/0974-2727.66703 | pmc=3147080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21814401  }} </ref>: This occurs due to anemia and loss of oxygen-carrying ability of blood. Pallor can occur in the [[skin]] or [[mucous membrane]] . In one population, 89% of patients with hemolytic anemia presented with pallor, and this is the most common physical exam finding in hemolytic anemia.
*'''[[Splenomegaly]]'''<ref name="pmid21814401">{{cite journal| author=Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK| title=Clinical patterns and hematological spectrum in autoimmune hemolytic anemia. | journal=J Lab Physicians | year= 2010 | volume= 2 | issue= 1 | pages= 17-20 | pmid=21814401 | doi=10.4103/0974-2727.66703 | pmc=3147080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21814401  }} </ref>: In the case of extravascular hemolysis, the spleen can be enlarged. The spleen is the site of destruction of the red blood cells. The spleen tip is measured in centimeters below the left costal margin. Massive splenomegaly can be readily palpated as a firm left-sided abdominal mass, though this is a rare presentation in the case of hemolytic anemia. Massive splenomegaly is more often seen in conditions in which the bone marrow is replaced by fibrous tissue like myelofibrosis, during which the compensatory mechanism is extramedullar hematopoiesis in the spleen. In one population, 81% of patients with hemolytic anemia presented with splenomegaly.
*'''[[Splenomegaly]]'''<ref name="pmid21814401">{{cite journal| author=Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK| title=Clinical patterns and hematological spectrum in autoimmune hemolytic anemia. | journal=J Lab Physicians | year= 2010 | volume= 2 | issue= 1 | pages= 17-20 | pmid=21814401 | doi=10.4103/0974-2727.66703 | pmc=3147080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21814401  }} </ref>: In the case of extravascular hemolysis, the spleen can be enlarged. The spleen is the site of destruction of the red blood cells. The spleen tip is measured in centimeters below the left costal margin. Massive splenomegaly can be readily palpated as a firm left-sided abdominal mass, though this is a rare presentation in the case of hemolytic anemia. Massive splenomegaly is more often seen in conditions in which the bone marrow is replaced by fibrous tissue like myelofibrosis, during which the compensatory mechanism is extramedullar hematopoiesis in the spleen. In one population, 81% of patients with hemolytic anemia presented with splenomegaly.

Revision as of 06:32, 27 October 2017

Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia physical examination

CDC on Hemolytic anemia physical examination

Hemolytic anemia physical examination in the news

Blogs on Hemolytic anemia physical examination

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

The physical examination findings of hemolytic anemia reflect (1) red blood cell loss and (2) the release of hemoglobin and its breakdown productions into the circulation. Typical exam findings include jaundice, pallor, splenomegaly, and hepatomegaly.

Physical Examination

Exam findings in hemolytic anemia include:

  • Jaundice: The symptoms of hemolysis mostly relate to (1) red blood cell loss and (2) release of hemoglobin and its breakdown products into the circulation. The breakdown products of hemoglobin will accumulate in the blood causing jaundice and be excreted in the urine causing the urine to become dark brown in color. [1]: This is due to Increased serum bilirubin levels in blood. Bilirubin is a breakdown product of hemoglobin. In one population, 43% of patients with hemolytic anemia presented with jaundice. Hemoglobin is first convereted to biliverdin then bilirubin. Jaundice can present as yellow discoloration of the skin or mucus membranes. It is a reflect of indirect (unconjugated) hyperbilirubinemia.
  • Pallor[1]: This occurs due to anemia and loss of oxygen-carrying ability of blood. Pallor can occur in the skin or mucous membrane . In one population, 89% of patients with hemolytic anemia presented with pallor, and this is the most common physical exam finding in hemolytic anemia.
  • Splenomegaly[1]: In the case of extravascular hemolysis, the spleen can be enlarged. The spleen is the site of destruction of the red blood cells. The spleen tip is measured in centimeters below the left costal margin. Massive splenomegaly can be readily palpated as a firm left-sided abdominal mass, though this is a rare presentation in the case of hemolytic anemia. Massive splenomegaly is more often seen in conditions in which the bone marrow is replaced by fibrous tissue like myelofibrosis, during which the compensatory mechanism is extramedullar hematopoiesis in the spleen. In one population, 81% of patients with hemolytic anemia presented with splenomegaly.
  • Hepatomegaly: Hepatomegaly, or liver enlargement, is a relatively uncommon presentation of hemolytic anemia. In one population, 76% of patients with hemolytic anemia presented with hepatomegaly. Hepatomegaly is measured in centimeters below the right costal margin.
  • Fever: This can be a rare manifestation of hemolytic anemia. Fever is not specific for hemolysis. In one population, 38% of patients with hemolytic anemia presented with fever.

References

  1. 1.0 1.1 1.2 Alwar V, Shanthala DA, Sitalakshmi S, Karuna RK (2010). "Clinical patterns and hematological spectrum in autoimmune hemolytic anemia". J Lab Physicians. 2 (1): 17–20. doi:10.4103/0974-2727.66703. PMC 3147080. PMID 21814401.

Template:WS Template:WH